Flu shot or NOT
Topic: Health & Well-being
"Hey Tige," I said to Mr. Tiger, the stubborn and inflexible inner pest, "are you aware of the latest on the flu shots?"

'I've heard that the Center for Disease Control is urging all Americans to get their flu shots,' answered Mr. Tiger before showing off how knowledgeable he can be, 'Tamiflu, an anti influenza drug, can reduce the duration of symptoms.'

"Yes," I responded quickly, " only 50% of the time." And then without wasting mine to talk about the particulars of the neuraminidase inhibitor drug I asked another question. "But did you know that it has the harmful preservative mercury in it? And did you know that more than 100 new cases of adverse side effects have been reported?

'Mostly from kids in Japan,' answered Tiger as if that fact should immediately halt our discussion.

In spite of his callousness, I continued with, "Serious skin reactions, and bizarre neuropsychiatric events, such as delirium and hallucinations. And last year," I added to top this off, "12 deaths were said to be a reaction to taking Tamiflu."

Tiger shrugged while saying, 'What can you do?'

"When you hear all the media boosts calling for a demand for this so-called vaccine - without also mentioning the correlation between between the drug and the unusual side effects - a good first step is to ask some questions," I responded.

'I have none,' he shot back.

Instead of arguing with this kind of nonsense, I said, "Take note," as I linked to Mom's Against Flu Shots and a pasted page 1 from today's ABC News story, FDA: Tamiflu Patients Need Monitoring.

WASHINGTON Nov 14, 2006 (AP)— More than 100 recent cases of delirium, hallucinations and other unusual psychiatric behavior in Japanese patients treated with Tamiflu should have parents watching for similar reactions when treating their children with the flu drug.

That's the new advice from the Food and Drug Administration in adding a new precaution to the label of the influenza drug, prescribed about 2 million times a year in the United States.

The FDA updated the label after receiving the 103 reports of abnormal behavior, most of which involved children in Japan. Japan uses more Tamiflu than any other country in the world, with more than 30 million prescriptions since 2001. It's been prescribed about 8 million times in the U.S. since 1999.

The FDA said a relationship between the drug and the behavior had not been established and that the updated label was "intended to mitigate a potential risk associated with Tamiflu." It recommends that close monitoring of patients begin immediately after starting treatment with the drug.

The changes bring the U.S. label more in line with the Japanese one, which already warned that such abnormal behavior could occur. The previous FDA-approved label mentioned only that "seizure and confusion" had been seen in some patients.

Tamiflu is made by the Swiss pharmaceutical company Roche Holding AG. Roche spokesman Terence Hurley said there was no evidence the drug caused the rarely occurring adverse events.

Both Roche and the FDA also said that severe cases of the flu can spark the abnormal behavior flagged in the updated label.

Furthermore, the FDA acknowledged that stopping treatment with Tamiflu could actually harm influenza patients if the virus is the cause of delirium, hallucinations and other abnormal behavior, such as aggression and suicidal thoughts.

Health officials have been sensitive about taking any action that might dissuade people from taking Tamiflu, since the drug could play an important role in an outbreak of bird flu. The drug doesn't prevent flu but can reduce the length and severity of its symptoms.

--
page 2 continues.